UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): | January 28, 2015 |
AMETEK, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
Delaware | 1-12981 | 14-1682544 |
_____________________ (State or other jurisdiction |
_____________ (Commission |
______________ (I.R.S. Employer |
of incorporation) | File Number) | Identification No.) |
1100 Cassatt Road, Berwyn, Pennsylvania | 19312 | |
_________________________________ (Address of principal executive offices) |
___________ (Zip Code) |
Registrants telephone number, including area code: | 610-647-2121 |
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02 Results of Operations and Financial Condition.
On January 28, 2015, AMETEK, Inc. issued a press release announcing its financial results for the three months and year ended December 31, 2014. A copy of such press release is furnished as Exhibit 99.1 to this Current Report.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
99.1 Copy of press release issued by AMETEK, Inc. on January 28, 2015 (furnished but not filed pursuant to Item 2.02).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
AMETEK, Inc. | ||||
January 28, 2015 | By: |
/s/ William J. Burke
|
||
|
||||
Name: William J. Burke | ||||
Title: Senior Vice President - Comptroller & Treasurer |
Exhibit Index
Exhibit No. | Description | |
|
|
|
99.1
|
Copy of press release issued by AMETEK, Inc. on January 28, 2015. |
Exhibit 99.1
CORPORATE OFFICE
1100 Cassatt Road, Berwyn, PA 19312
Contact: Kevin C. Coleman (610) 889-5247
AMETEK ANNOUNCES RECORD FOURTH QUARTER 2014 RESULTS
Fourth Quarter Adjusted Earnings per Share up 15%
Berwyn, PA, January 28, 2015 AMETEK, Inc. (NYSE: AME) today announced its financial results for the three month and full year periods ended December 31, 2014.
AMETEKs fourth quarter 2014 sales of $1.02 billion were up 9% over the same period of 2013. Excluding Zygo integration costs of $5.2 million, or approximately $0.01 per diluted share, operating income increased 10% to a record $232.3 million, operating margins were up 40 basis points, and diluted earnings per share increased 15% to a record $0.63 per diluted share from the fourth quarter 2013.
AMETEK had a strong fourth quarter to complete another excellent year. Strong growth, record operating performance, and the contributions from our acquired businesses allowed us to exceed our fourth quarter earnings expectations. In addition, our orders were very strong in the quarter, totaling $1.0 billion, up 10% from last years fourth quarter with 7% core growth, noted Frank S. Hermance, AMETEK Chairman and Chief Executive Officer.
Cash flow was also very strong, with both the fourth quarter and full year results representing records. Operating cash flow was $213.3 million for the quarter and $726.0 million for the year, continued Mr. Hermance.
For the full year, AMETEK achieved record levels of orders, sales, operating income, net income and diluted earnings per share. Full year sales were $4.02 billion, up 12% from 2013. Excluding Zygo integration costs of $18.9 million, or approximately $0.05 per diluted share, operating income in 2014 was $917.5 million, up 13%, and diluted earnings per share were $2.42, up 15% from 2013.
On a GAAP basis, in the fourth quarter operating income was $227.1 million and diluted earnings per share were $0.62. For the full year, operating income was $898.6 million, and diluted earnings per share were $2.37. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying the release.
MORE
AMETEK ANNOUNCES RECORD FOURTH QUARTER 2014 RESULTS
Page 2
Electronic Instruments Group (EIG)
For the 2014 fourth quarter, EIG sales increased 14% to $644.4 million. Operating income, excluding
the Zygo integration costs, increased 11% to $168.1 million over the fourth quarter of 2013.
EIG had a very solid fourth quarter. Strong sales growth was driven by excellent organic growth in our Aerospace business, combined with contributions from our recent acquisitions, notes Mr. Hermance.
On a GAAP basis, EIG operating income was $162.9 million.
Electromechanical Group (EMG)
In the fourth quarter, EMG sales increased 1% to $379.8 million. Operating income in the fourth
quarter increased 9% to $77.0 million. Operating margins for the quarter were 20.3%, up 150 basis
points from last years fourth quarter.
EMG performed very well in the quarter with excellent operating performance and solid core growth in our Precision Motion Control and Engineered Materials, Interconnects and Packaging businesses. Operating margins were up sharply driven by the sales growth and our continued Operational Excellence initiatives, adds Mr. Hermance.
2015 Outlook
We expect our businesses overall to show solid growth in 2015. AMETEKs strong portfolio of
differentiated businesses, proven operational capabilities, continued investment in new product
development and geographic expansion, and a continued focus on strategic acquisitions should enable
us to perform well in 2015 and beyond, notes Mr. Hermance.
We anticipate 2015 revenue to be up mid-single digits on a percentage basis from 2014. Earnings for 2015 are expected to be in the range of $2.58 to $2.63 per diluted share, up 7% to 9% over 2014, reflecting the leveraged impact of core growth, continued operational excellence initiatives, and the benefit of contributions from recent acquisitions, adds Mr. Hermance.
First quarter 2015 sales are expected to be up mid-single digits from last years first quarter. We estimate our earnings to be approximately $0.61 to $0.63 per diluted share, an increase of 7% to 11% over last years first quarter of $0.57 per diluted share, concludes Mr. Hermance.
MORE
AMETEK ANNOUNCES RECORD FOURTH QUARTER 2014 RESULTS
Page 3
Conference Call
AMETEK will webcast its Fourth Quarter 2014 investor conference call on Wednesday, January 28,
2015, beginning at 8:30 AM ET. The live audio webcast will be available at the Investors section of
www.ametek.com and at www.streetevents.com. The call will also be archived at the
Investors section of www.ametek.com.
Corporate Profile
AMETEK is a leading global manufacturer of electronic instruments and electro-mechanical devices
with 2014 sales of $4.0 billion. AMETEKs Corporate Growth Plan is based on Four Key Strategies:
Operational Excellence, Strategic Acquisitions, Global & Market Expansion and New Products.
AMETEKs objective is double-digit percentage growth in earnings per share over the business cycle
and a superior return on total capital. The common stock of AMETEK is a component of the S&P 500
Index.
Forward-looking Information
Statements in this news release relating to future events, such as AMETEKs expected business and
financial performance are forward-looking statements. Forward-looking statements are subject to
various factors and uncertainties that may cause actual results to differ significantly from
expectations. These factors and uncertainties include our ability to consummate and successfully
integrate future acquisitions; risks associated with international sales and operations; our
ability to successfully develop new products, open new facilities or transfer product lines; the
price and availability of raw materials; compliance with government regulations, including
environmental regulations; changes in the competitive environment or the effects of competition in
our markets; the ability to maintain adequate liquidity and financing sources; and general economic
conditions affecting the industries we serve. A detailed discussion of these and other factors
that may affect our future results is contained in AMETEKs filings with the U.S. Securities and
Exchange Commission, including its most recent reports on Form 10-K, 10-Q and 8-K. AMETEK
disclaims any intention or obligation to update or revise any forward-looking statements.
# # #
(Financial Information Follows)
AMETEK, Inc.
Consolidated Statement of Income
(In thousands, except per share amounts)
Three Months Ended | Year Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||||||||||||
Net sales |
$ | 1,024,143 | $ | 942,468 | $ | 4,021,964 | $ | 3,594,136 | ||||||||||||||||
Operating expenses: |
||||||||||||||||||||||||
Cost of sales, excluding depreciation |
663,463 | 609,845 | 2,597,017 | 2,323,642 | ||||||||||||||||||||
Selling, general and administrative |
117,491 | 106,688 | 462,637 | 398,177 | ||||||||||||||||||||
Depreciation |
16,105 | 15,390 | 63,724 | 57,238 | ||||||||||||||||||||
Total operating expenses |
797,059 | 731,923 | 3,123,378 | 2,779,057 | ||||||||||||||||||||
Operating income |
227,084 | 210,545 | 898,586 | 815,079 | ||||||||||||||||||||
Other expenses: |
||||||||||||||||||||||||
Interest expense |
(22,566 | ) | (18,852 | ) | (79,928 | ) | (73,572 | ) | ||||||||||||||||
Other, net |
3,016 | (5,230 | ) | (13,826 | ) | (16,712 | ) | |||||||||||||||||
Income before income taxes |
207,534 | 186,463 | 804,832 | 724,795 | ||||||||||||||||||||
Provision for income taxes |
55,534 | 50,795 | 220,372 | 207,796 | ||||||||||||||||||||
Net income |
$ | 152,000 | $ | 135,668 | $ | 584,460 | $ | 516,999 | ||||||||||||||||
Diluted earnings per share |
$ | 0.62 | $ | 0.55 | $ | 2.37 | $ | 2.10 | ||||||||||||||||
Basic earnings per share |
$ | 0.62 | $ | 0.55 | $ | 2.39 | $ | 2.12 | ||||||||||||||||
Weighted average common shares
outstanding: |
||||||||||||||||||||||||
Diluted shares |
246,132 | 246,816 | 247,102 | 246,065 | ||||||||||||||||||||
Basic shares |
243,990 | 244,659 | 244,885 | 243,915 | ||||||||||||||||||||
Dividends per share |
$ | 0.09 | $ | 0.06 | $ | 0.33 | $ | 0.24 | ||||||||||||||||
AMETEK, Inc.
Information by Business Segment
(In thousands)
Three Months Ended | Year Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||||||||||||
Net sales: |
||||||||||||||||||||||||
Electronic Instruments |
$ | 644,386 | $ | 566,907 | $ | 2,421,638 | $ | 2,034,594 | ||||||||||||||||
Electromechanical |
379,757 | 375,561 | 1,600,326 | 1,559,542 | ||||||||||||||||||||
Consolidated net sales |
$ | 1,024,143 | $ | 942,468 | $ | 4,021,964 | $ | 3,594,136 | ||||||||||||||||
Income: |
||||||||||||||||||||||||
Segment operating income: |
||||||||||||||||||||||||
Electronic Instruments |
$ | 162,861 | $ | 151,855 | $ | 612,992 | $ | 552,110 | ||||||||||||||||
Electromechanical |
77,032 | 70,528 | 335,046 | 309,402 | ||||||||||||||||||||
Total segment operating income |
239,893 | 222,383 | 948,038 | 861,512 | ||||||||||||||||||||
Corporate administrative and
other expenses |
(12,809 | ) | (11,838 | ) | (49,452 | ) | (46,433 | ) | ||||||||||||||||
Consolidated operating income |
$ | 227,084 | $ | 210,545 | $ | 898,586 | $ | 815,079 | ||||||||||||||||
AMETEK, Inc.
Condensed Consolidated Balance Sheet
(In thousands)
December 31, | December 31, | |||||||||||
2014 | 2013 | |||||||||||
(Unaudited) | ||||||||||||
ASSETS |
||||||||||||
Current assets: |
||||||||||||
Cash and cash equivalents |
$ | 377,615 | $ | 295,203 | ||||||||
Receivables, net |
585,462 | 536,701 | ||||||||||
Inventories |
495,896 | 452,848 | ||||||||||
Other current assets |
128,853 | 84,377 | ||||||||||
Total current assets |
1,587,826 | 1,369,129 | ||||||||||
Property, plant and equipment, net |
448,446 | 402,790 | ||||||||||
Goodwill |
2,611,270 | 2,408,363 | ||||||||||
Other intangibles, investments and other assets |
1,766,976 | 1,697,620 | ||||||||||
Total assets |
$ | 6,414,518 | $ | 5,877,902 | ||||||||
LIABILITIES AND STOCKHOLDERS EQUITY |
||||||||||||
Current liabilities: |
||||||||||||
Short-term borrowings and current portion of long-term debt |
$ | 286,201 | $ | 273,315 | ||||||||
Accounts payable and accruals |
658,194 | 601,230 | ||||||||||
Total current liabilities |
944,395 | 874,545 | ||||||||||
Long-term debt |
1,427,825 | 1,141,750 | ||||||||||
Deferred income taxes and other long-term liabilities |
800,482 | 725,486 | ||||||||||
Stockholders equity |
3,241,816 | 3,136,121 | ||||||||||
Total liabilities and stockholders equity |
$ | 6,414,518 | $ | 5,877,902 | ||||||||
AMETEK, Inc.
Reconciliations of GAAP to Non-GAAP Financial Measures
(In millions, except per share amounts)
(Unaudited)
Three Months Ended | Year Ended | |||||||||||||||||||||||
December 31, | December 31, | |||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||
EIG Segment operating income (GAAP) |
$ | 162.9 | $ | 151.9 | $ | 613.0 | $ | 552.1 | ||||||||||||||||
Zygo integration costs |
5.2 | | 18.9 | | ||||||||||||||||||||
Adjusted EIG Segment operating income (Non-GAAP) |
$ | 168.1 | $ | 151.9 | $ | 631.9 | $ | 552.1 | ||||||||||||||||
Operating income (GAAP) |
$ | 227.1 | $ | 210.5 | $ | 898.6 | $ | 815.1 | ||||||||||||||||
Zygo integration costs |
5.2 | | 18.9 | | ||||||||||||||||||||
Adjusted Operating income (Non-GAAP) |
$ | 232.3 | $ | 210.5 | $ | 917.5 | $ | 815.1 | ||||||||||||||||
Net income (GAAP) |
$ | 152.0 | $ | 135.7 | $ | 584.5 | $ | 517.0 | ||||||||||||||||
Zygo integration costs |
3.2 | (1) | | 13.9 | (2) | | ||||||||||||||||||
Adjusted Net income (Non-GAAP) |
$ | 155.2 | $ | 135.7 | $ | 598.4 | $ | 517.0 | ||||||||||||||||
(1) Represents fourth quarter adjustments at 39.2% tax rate. |
||||||||||||||||||||||||
(2) Represents full year adjustments at 26.4% tax rate. |
||||||||||||||||||||||||
Diluted earnings per share (GAAP) |
$ | 0.62 | $ | 0.55 | $ | 2.37 | $ | 2.10 | ||||||||||||||||
Zygo integration costs |
0.01 | | 0.05 | | ||||||||||||||||||||
Adjusted diluted earnings per share (Non-GAAP) |
$ | 0.63 | $ | 0.55 | $ | 2.42 | $ | 2.10 | ||||||||||||||||
Operating income margin (GAAP) |
22.2 | % | 22.3 | % | ||||||||||||||||||||
Zygo integration costs |
0.5 | % | 0.0 | % | ||||||||||||||||||||
Adjusted Operating income margin (GAAP) |
22.7 | % | 22.3 | % | ||||||||||||||||||||
Use of Non-GAAP Financial Information
The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles (GAAP) basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making. Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.
The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEKs operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers. The items described above have been excluded from this measure because items of this nature and/or size occur with inconsistent frequency, occur for reasons that may be unrelated to AMETEKs commercial performance during the period and/or we believe are not indicative of AMETEKs ongoing operating costs or gains in a given period, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.